Literature DB >> 2729411

Lymphocyte proliferative responses of patients with ocular toxoplasmosis to parasite and retinal antigens.

R B Nussenblatt1, K K Mittal, S Fuhrman, S D Sharma, A G Palestine.   

Abstract

In vitro lymphocyte proliferative responses to purified toxoplasma antigens and the retinal S-antigen were evaluated in 40 patients with ocular toxoplasmosis; 16 (40%) had a positive in vitro response to the retinal S-antigen. The proliferative responses to the 2G11 (p22) toxoplasma membrane antigen approached that of a crude antigen preparation of Toxoplasma gondii, whereas the response to the 1E11 immunodominant p30 membrane antigen was considerably less striking. HLA typing was also performed, and none correlated to S-antigen or toxoplasma reactivity. The evidence strongly suggests that patients with a clearly infectious ocular disorder may have part of their disease mediated by a putative autoimmune mechanism. An immune response to the 2G11 toxoplasma antigen may increase the risk of developing ocular disease or a substrain of toxoplasma with 2G11 as its immunodominant membrane antigen may have a greater affinity for the retina.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2729411     DOI: 10.1016/0002-9394(89)90260-2

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  17 in total

1.  Aqueous humor and serum immunoblotting for immunoglobulin types G, A, M, and E in cases of human ocular toxoplasmosis.

Authors:  Justus G Garweg; Silvia-Daniela L Garweg; Franziska Flueckiger; Patrick Jacquier; Matthias Boehnke
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

Review 2.  The natural history of uveitis.

Authors:  R B Nussenblatt
Journal:  Int Ophthalmol       Date:  1990-10       Impact factor: 2.031

Review 3.  Immunity and Toxoplasma retinochoroiditis.

Authors:  G R Wallace; M R Stanford
Journal:  Clin Exp Immunol       Date:  2008-06-28       Impact factor: 4.330

Review 4.  Ocular involvement in toxoplasmosis.

Authors:  A Rothova
Journal:  Br J Ophthalmol       Date:  1993-06       Impact factor: 4.638

5.  Value of PCR for detection of Toxoplasma gondii in aqueous humor and blood samples from immunocompetent patients with ocular toxoplasmosis.

Authors:  G Bou; M S Figueroa; P Martí-Belda; E Navas; A Guerrero
Journal:  J Clin Microbiol       Date:  1999-11       Impact factor: 5.948

6.  HLA typing in congenital toxoplasmosis.

Authors:  C Meenken; A Rothova; L P de Waal; A R van der Horst; B J Mesman; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1995-05       Impact factor: 4.638

7.  Anti-retinal autoantibodies in experimental ocular and systemic toxoplasmosis.

Authors:  Justus G Garweg; Yvonne de Kozak; Brigitte Goldenberg; Matthias Boehnke
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-12-03       Impact factor: 3.117

8.  Cellular autoimmunity to retinal specific antigens in patients with Behçet's disease.

Authors:  J H Yamamoto; M Minami; G Inaba; K Masuda; M Mochizuki
Journal:  Br J Ophthalmol       Date:  1993-09       Impact factor: 4.638

9.  Does autoimmunity to S-antigen play a role in Fuchs' heterochromic cyclitis?

Authors:  E La Hey; L Broersma; R van der Gaag; G S Baarsma; A Rothova; A Kijlstra
Journal:  Br J Ophthalmol       Date:  1993-07       Impact factor: 4.638

10.  Cellular immune response of patients with uveitis to peptide M, a retinal S-antigen fragment.

Authors:  S Nityanand; V K Singh; T Shinohara; A K Paul; V Singh; P K Agarwal; S S Agarwal
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.